Brilliance Phototherapy Device


last updated 5 days ago


Product description

A blue LED-based phototherapy device for treatment of neonatal jaundice.

Target region(s)
India, Kenya, Malawi, Myanmar, Nepal, Pakistan, Philippines, South Africa, Uganda, United Republic of Tanzania
Distributors/implementing organizations

Phoenix Medical Systems Private Ltd in Chennai India manufactures, distributes, and sells Brilliance under a license from [D-Rev] ( “Brilliance Blog Post – December 22, 2010”)

Market suggested retail price

Retail $400 USD (22,000 INR) in India, [$500 USD outside of India]( “Brilliance Blog Post – December 22, 2010”)

Competitive landscape

Firefly; Medela Bilibed; Draeger Photo-Therapy; BluLine Phototherapy; Breath of Life (BOL) Phototherapy; Natus neoBLUE

SDG targeted

Goal [3] ( “”): to improve and promote good health.

Newborns with mild to severe jaundice. 1 in 6 babies require treatment for jaundice. If not treated these babies are at risk of brain damage or death.

Target user(s)

[Hospitals and clinics] ( “”) with neonatal intensive care units (NICUs) or special newborn care units (SNCUs) in developing countries.

The @AutodeskFdn blogged about our how-to guide for communities writing proposals for development projects